Letter to the Editor
Cilostazol: Several issues to be considered about the safety profile
Cilostazol: Varios factores a tener en cuenta sobre el perfil de seguridad
Hiroshi Ito
Division of Hospital Medicine, University of Tsukuba Hospital, 2-1-1 Amakubo, Tsukuba, Ibaraki 305-8576, Japan
Read
6939
Timeswas read the article
2047
Total PDF
4892
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 11 | 163 | 57 | 220 |
| 2025 10 | 181 | 53 | 234 |
| 2025 9 | 100 | 47 | 147 |
| 2025 8 | 90 | 63 | 153 |
| 2025 7 | 79 | 34 | 113 |
| 2025 6 | 117 | 38 | 155 |
| 2025 5 | 113 | 32 | 145 |
| 2025 4 | 70 | 28 | 98 |
| 2025 3 | 106 | 59 | 165 |
| 2025 2 | 82 | 45 | 127 |
| 2025 1 | 72 | 32 | 104 |
| 2024 12 | 68 | 44 | 112 |
| 2024 11 | 69 | 54 | 123 |
| 2024 10 | 54 | 57 | 111 |
| 2024 9 | 53 | 47 | 100 |
| 2024 8 | 77 | 89 | 166 |
| 2024 7 | 60 | 39 | 99 |
| 2024 6 | 77 | 47 | 124 |
| 2024 5 | 118 | 45 | 163 |
| 2024 4 | 75 | 48 | 123 |
| 2024 3 | 73 | 25 | 98 |
| 2024 2 | 82 | 42 | 124 |
| 2024 1 | 97 | 30 | 127 |
| 2023 12 | 227 | 23 | 250 |
| 2023 11 | 333 | 82 | 415 |
| 2023 10 | 357 | 71 | 428 |
| 2023 9 | 258 | 55 | 313 |
| 2023 8 | 122 | 31 | 153 |
| 2023 7 | 83 | 26 | 109 |
| 2023 6 | 75 | 11 | 86 |
| 2023 5 | 97 | 29 | 126 |
| 2023 4 | 80 | 14 | 94 |
| 2023 3 | 97 | 20 | 117 |
| 2023 2 | 75 | 23 | 98 |
| 2023 1 | 88 | 26 | 114 |
| 2022 12 | 66 | 35 | 101 |
| 2022 11 | 109 | 34 | 143 |
| 2022 10 | 90 | 37 | 127 |
| 2022 9 | 67 | 21 | 88 |
| 2022 8 | 72 | 53 | 125 |
| 2022 7 | 63 | 41 | 104 |
| 2022 6 | 57 | 45 | 102 |
| 2022 5 | 68 | 30 | 98 |
| 2022 4 | 98 | 70 | 168 |
| 2022 3 | 40 | 46 | 86 |
| 2022 2 | 44 | 38 | 82 |
| 2022 1 | 40 | 45 | 85 |
| 2021 12 | 38 | 37 | 75 |
| 2021 11 | 52 | 32 | 84 |
| 2021 10 | 20 | 17 | 37 |
Show all
